Home Infusion Therapy Market Key Manufacturers Development Trends and Competitive Analysis 2028

The "Home Infusion Therapy Market" was valued at US$ 21,765.95 million in 2022 and is expected to reach US$ 35,696.05 million by 2028; it is estimated to record a CAGR of 8.6% from 2022 to 2028.

The increasing incidences of chronic disorders coupled with the rising geriatric population, and the reducing duration of hospital stays and the surging cost of care are driving the home infusion therapy market development. However, recalls of infusion pumps and safety concerns associated with home infusion hamper the home infusion therapy market growth.

Get a Sample PDF of report @: https://www.premiummarketinsights.com/sample/TIP00012592?utm_source=OpenPr&utm_medium=10688

Companies Profiled in this report includes:

• B. Braun Melsungen AG
• Micrel Medical Devices SA
• Baxter International Inc
• Nipro Corp
• Becton Dickinson and Co
• Fresenius Kabi AG
• ICU Medical Inc
• JMS Co Ltd
• Eitan Medical Ltd
• Terumo Corp

According to the National Home Infusion Association (NHIA), 3.2 million patients receive home infusion every year, and 98% of these admitted are being "very satisfied" with their treatment. According to a study by the NHIA in 2019, home infusion and specialty providers in the US served ~3 million patients in 2019, reporting a 300% increase in their sales in the last decade. Home infusion imparts significant cost-savings compared to a traditional hospital infusion setting. Infusion provided at home costs 50% less than infusion provided at hospital facilities. According to the article published by Beckers Hospital in 2020, the average cost of home infusion is US$ 140-250 per day, whereas the average cost of hospital infusions is US$ 590 per patient per infusion. According to the Commonwealth Fund, hospital-at-home programs help to cut the cost of care by over 30%, doing remarkably well in countries with single-payer systems, such as Canada, England, and Israel.

Get Full Report here @: https://www.premiummarketinsights.com/reports-tip/home-infusion-therapy-market

Home Infusion Therapy Market Segmentation:

By Product:
• Infusion Pumps
• Intravenous SetsIV Cannulas
• Needleless Connectors

By Application:
• Anti-Infective
• Endocrinology
• Enteral Nutrition
• Specialty Pharmaceuticals
• Hydration Therapy
• Chemotherapy

By Route of Administration:
• Intramuscular
• Subcutaneously
• Epidural

According to the National Home Infusion Association (NHIA), 3.2 million patients receive home infusion every year, and 98% of these admitted are being "very satisfied" with their treatment. According to a study by the NHIA in 2019, home infusion and specialty providers in the US served ~3 million patients in 2019, reporting a 300% increase in their sales in the last decade. Home infusion imparts significant cost-savings compared to a traditional hospital infusion setting. Infusion provided at home costs 50% less than infusion provided at hospital facilities. According to the article published by Beckers Hospital in 2020, the average cost of home infusion is US$ 140-250 per day, whereas the average cost of hospital infusions is US$ 590 per patient per infusion. According to the Commonwealth Fund, hospital-at-home programs help to cut the cost of care by over 30%, doing remarkably well in countries with single-payer systems, such as Canada, England, and Israel.

Buy this Report @: https://www.premiummarketinsights.com/buy/TIP00012592?utm_source=OpenPr&utm_medium=10688

Patients requiring intravenous therapies in emergency departments can be shifted to home infusion after clinical assessment. The homecare plan includes robust clinical monitoring at home, which allows the early identification of further clinical problems and the implementation of treatment plans to avoid readmissions. An Option Care study of 124 home parenteral nutrition (HPN) and 126 home enteral nutrition (HEN) patients showed that home infusion prevents hospitalization and improves patient care. Both HPN and HEN therapies can be temporarily administered in hospitals, yet ~40,000 HPN patients and 344,000 HEN patients yearly receive their nutrition therapies at home. Therefore, a significant reduction in the cost of care with a decrease in the length of hospital stays, along with the increasing number of patients availing homecare services, fuel the home infusion therapy market growth.

Contact Us:

If you have any queries about this report or if you would like further information, please
Contact Person: Sameer Joshi
Phone: +1-646-491-9876
Email: sales@premiummarketinsights.com

About Us:

Premium Market Insights is a one stop shop of market research reports and solutions to various companies across the globe. We help our clients in their decision support system by helping them choose most relevant and cost-effective research reports and solutions from various publishers.
The market research industry has changed in last decade. As corporate focus has shifted to niche markets and emerging countries, a number of publishers have stepped in to fulfil these information needs. We have experienced and trained staff that helps you navigate different options and lets you choose best research solution at most effective cost.
Premium Market Insights has an extensive coverage of industry reports, company reports and country reports across all industries. In case your research needs are not met by syndicated reports offered by leading publishers, we can help you by offering a customized research solution by liaising with different research agencies saving your valuable time and money.
We provide best in class customer service and our customer support team is always available to help you on your research queries. Our commitment to customer service is best exemplified by free analyst support that we offer to our clients which sets us apart from any other provider. We also offer enterprise subscriptions which provide significant cost savings to our clients.

This release was published on openPR.